Merck donates half a million dollars to combat maternal mortality in Haiti
KIRKLAND, QC, Nov. 12, 2012 /CNW Telbec/ - Merck is pleased to announce a
grant of $500,000 to the Centre de coopération internationale en santé et
développement (Center for International Cooperation in Health and Development
or CCISD) based in Quebec City. The donation is part of Merck for Mothers
Global Giving Program which aims to support philanthropic organizations that
are dedicated to improving maternal health and, ultimately, help reduce the
number of women who die or suffer disabilities from pregnancy and
childbirth-related complications. Approximately 20 projects were chosen around
the world, including CCISD which will be directing the funds towards a
maternal health project targeting the Artibonite communities of Anse Rouge,
Terre Neuve and Ennery in Haiti.
"We are very pleased to be supporting CCISD's new program aimed at
strengthening maternal health services in Haiti," said Cyril Schiever,
President and Managing Director of Merck Canada Inc. "CCISD does impressive
work around the world promoting both primary care and women's health and
aligns perfectly with the objectives of the Merck for Mothers program, which
is dedicated to creating a world where no woman has to die from complications
of pregnancy and childbirth."
The CCISD has been implementing international health projects for over 25
years. Starting in January 2013, they will direct the Merck for Mothers grant
to a project complementary to their 'Integrated Management of Maternal and
Child Health' program - also known as PRISMA - in the Artibonite region in
Haiti. "Haiti has the highest maternal mortality rate in the northern
hemisphere(1). Funding to provide access to services and medical supplies is
essential to help save lives in this country," said Robert Beaudry, Executive
Director of CCISD. "Of all those burdened with the lack of access to proper
healthcare, some of the saddest stories are about the preventable deaths of
mothers and newborns."
According to Martine Bernier, Project Director of the PRISMA program in Haiti,
"Only in the intervention area of the project that will be supported by the
Merck for Mothers grant, over 1,600 women become pregnant every year. The cost
and accessibility of prenatal and delivery services can be huge obstacles to
Haitian mothers. This much-needed donation will help provide better access to
services and, ultimately, lower the complications and mortality rates of women
and newborns in this area."
About Merck for Mothers
Over the next decade, it is estimated that nearly three million women will die
from complications due to pregnancy and childbirth globally. The majority of
these deaths are preventable. When a woman dies, the ripple effect on families
and communities is enormous. Her baby is more likely to die before the age of
two and her other children are more likely to leave school, suffer from poor
health, and die prematurely.
Merck for Mothers is a 10-year, half-billion-dollar initiative to create a
world where no woman has to die from complications of pregnancy and
childbirth. Drawing on the company's history of discovering innovative,
life-saving medicines and vaccines, Merck for Mothers is applying the
company's scientific and business expertise to reduce maternal mortality
around the world.
In order to achieve our goals, our approach focuses on three main pillars:
product innovation, accelerating access to maternal health solutions and
services, as well as advocacy and awareness.
The Merck for Mothers Global Giving Programwill focus on helping countries
reduce maternal mortality and improve maternal health with the overall aim of
supporting the United Nations Millennium Development Goal (MDG) 5, which calls
for a 75% reduction in maternal mortality and universal access to reproductive
health by 2015.
For more information, please visit www.MerckforMothers.com
Today's Merck is a global healthcare leader working to help the world be well.
Merck is known as MSD outside the United States and Canada. Through our
medicines, vaccines, biologic therapies, and consumer and animal products, we
work with customers and operate in more than 140 countries to deliver
innovative health solutions. We also demonstrate our commitment to increasing
access to healthcare through far-reaching policies, programs and partnerships.
For more information about our operations in Canada, visit www.merck.ca.
Forward Looking Statement
This news release includes "forward-looking statements" within the meaning of
the safe harbor provisions of the United States Private Securities Litigation
Reform Act of 1995. Such statements may include, but are not limited to,
statements about the benefits of the merger between Merck and Schering-Plough,
including future financial and operating results, the combined company's
plans, objectives, expectations and intentions and other statements that are
not historical facts. Such statements are based upon the current beliefs and
expectations of Merck's management and are subject to significant risks and
uncertainties. Actual results may differ from those set forth in the
The following factors, among others, could cause actual results to differ from
those set forth in the forward-looking statements: the possibility that all of
the expected synergies from the merger of Merck and Schering-Plough will not
be realized, or will not be realized within the expected time period; the
impact of pharmaceutical industry regulation and health care legislation in
the United States and internationally; Merck's ability to accurately predict
future market conditions; dependence on the effectiveness of Merck's patents
and other protections for innovative products; and the exposure to litigation
and/or regulatory actions. Merck undertakes no obligation to publicly update
any forward-looking statement, whether as a result of new information, future
events or otherwise. Additional factors that could cause results to differ
materially from those described in the forward-looking statements can be found
in Merck's 2011 Annual Report on Form 10-K and the company's other filings
with the Securities and Exchange Commission (SEC) available at the SEC's
Internet site (www.sec.gov).
(1 )Médecins sans frontières, 2012. MSF in Haiti. Accessible en ligne :
(consulté en octobre 2012)
Attachment: PHOTO and caption
Media Contacts: Ani Armenian Merck 514-428-3395 Valérie Diamant
CCISD 418-656-5525 ext. 8319 Québec/Montréal Sylvie Patry/Roch
Landriault 418-648-1233 ext. 232/514-843-2345
Image with caption: "Jennifer Chan, Vice-President, Communications and Policy,
Merck Canada; Robert Beaudry, Executive Director, CCISD and Martine Bernier,
Project Director of the PRISMA program in Haiti. (CNW Group/MERCK)". Image
To view this news release in HTML formatting, please use the following URL:
CO: Center for International Cooperation in Health and Development (CCISD)
NI: MTC WNEWS HEA
-0- Nov/12/2012 22:26 GMT
Press spacebar to pause and continue. Press esc to stop.